NASDAQ:CTRX 71098 Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding 71098 Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume2.83 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.Read More MarketRank™Overall MarketRank™0.52 out of 5 starsAnalyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for 71098. Previous Next 2.6 Community Rank Outperform Votes71098 has received 237 “outperform” votes. (Add your “outperform” vote.)Underperform Votes71098 has received 219 “underperform” votes. (Add your “underperform” vote.)Community Sentiment71098 has received 51.97% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about 71098 and other stocks. Vote “Outperform” if you believe CTRX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTRX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend Yield71098 does not currently pay a dividend.Dividend Growth71098 does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 71098 insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Services SectorN/A Current SymbolNASDAQ:CTRX Previous SymbolNASDAQ:SXCI CUSIP14888710 CIK1363851 Webwww.catamaranrx.com Phone+1-800-2823232EmployeesN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive CTRX News and Ratings via Email Sign-up to receive the latest news and ratings for CTRX and its competitors with MarketBeat's FREE daily newsletter. 71098 (NASDAQ:CTRX) Frequently Asked Questions What stocks does MarketBeat like better than 71098? Wall Street analysts have given 71098 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 71098 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. How were 71098's earnings last quarter? 71098 (NASDAQ:CTRX) announced its quarterly earnings data on Thursday, February, 26th. The healthcare company reported $0.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.61 by $0.06. The healthcare company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.57 billion. The company's revenue for the quarter was up 26.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.56 EPS. View 71098's earnings history. Who are some of 71098's key competitors? Some companies that are related to 71098 include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Amedisys (AMED), Chemed (CHE), LHC Group (LHCG), AMN Healthcare Services (AMN), R1 RCM (RCM), The Providence Service (PRSC), MEDNAX (MD), CorVel (CRVL), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Biosciences (IDXG). View all of CTRX's competitors. What other stocks do shareholders of 71098 own? Based on aggregate information from My MarketBeat watchlists, some companies that other 71098 investors own include Intact Financial Co. (IFC.TO) (IFC), Constellation Software Inc. (CSU.TO) (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy Inc. (VET.TO) (VET), Wheaton Precious Metals Corp. (WPM.TO) (WPM), Rogers Communications (RCI), Open Text Co. (OTEX.TO) (OTEX) and Valeant Pharmaceuticals International, Inc. (VRX.TO) (VRX). What is 71098's stock symbol? 71098 trades on the NASDAQ under the ticker symbol "CTRX." What is 71098's official website? The official website for 71098 is www.catamaranrx.com. How can I contact 71098? 71098's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The healthcare company can be reached via phone at +1-800-2823232. This page was last updated on 1/24/2021 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here
